C12Y 117/01
Oxidoreductases acting on ch or ch2 groups: with nad+ or nadp+ as
Official title: with NAD+ or NADP+ as acceptor (1.17.1)
C12Y117/01 (Oxidoreductases acting on ch or ch2 groups: with nad+ or nadp+ as) appears on 19 US grants and 45 published applications in this corpus.
Search patents in C12Y- Granted patents
- 19
- Published applications
- 45
- Assignees
- 39
- Inventors
- 138
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 3 | 6 |
| 2023 | 2 | 7 |
| 2024 | 2 | 5 |
| 2025 | 2 | 9 |
| 2026 | 5 | 9 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 117/01003Leucoanthocyanidin reductase5
- C12Y 117/01004Xanthine dehydrogenase5
- C12Y 117/01001Cdp-4-dehydro-6-deoxyglucose reductase0
- C12Y 117/010024-hydroxy-3-methylbut-2-enyl diphosphate reductase0
- C12Y 117/01005Nicotinate dehydrogenase0
- C12Y 117/010073-oxo-5,6-dehydrosuberyl-coa semialdehyde dehydrogenase0
Recent patents
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Compositions and methods for inhibiting XDH expression18 Aug 2026US 12,709,752 B2Novo Nordisk A/S
- Process for producing formate using oxygen-tolerant enzymes16 Jun 2026US 12,655,454 B2Gwangju Institute of Science and Technology
- RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use19 May 2026US 12,630,826 B2Arrowhead Pharmaceuticals, Inc.
- Modified polypeptide of meso-diaminopimelate dehydrogenase and polynucleotide encoding the modified polypeptide17 Feb 2026US 12,553,056 B2Cj Cheiljedang Corporation
- Method for producing d-talitol, d-tagatose, and d-psicose8 Oct 2026US 2026/0308649 A1Annikki GmbH
- Method for producing allitol3 Sep 2026US 2026/0258453 A1Annikki GmbH
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Polyethylenimine-modified cry proteins and their use20 Aug 2026US 2026/0242428 A1The Chinese University of Hong Kong
- Variant isph and method for synthesizing compound having, as structural unit, isoprene obtained by using said variant enzyme13 Aug 2026US 2026/0234678 A1National University Corporation Chiba University
Most cited
By later US patents
- Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine reductase from clover, medic ryegrass or fescue85US 8,093,451 B2AgResearch Limited · 2012
- Enzymatic method for producing 2-hydroxy-4-methylmercaptobutanoic acid (MHA)3US 10,815,508 B2Evonik Operations GmbH · 2020
- Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof2US 11,326,166 B1Alnylam Pharmaceuticals, Inc. · 2022
- RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use2US 11,629,349 B2Arrowhead Pharmaceuticals, Inc. · 2023
- Corynebacterium sp. microorganisms having l-lysine-producing ability and l-lysine producing method using same1US 10,889,843 B2Cj Cheiljedang Corporation · 2021